Last reviewed · How we verify
Manitol
At a glance
| Generic name | Manitol |
|---|---|
| Sponsor | Reconnect Labs |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | discontinued |
Approved indications
Common side effects
Key clinical trials
- Efficacy and Safety of mAnniTol in Bowel Preparation: Assessment of Adequacy and Presence of Intestinal levelS of Hydrogen and Methane During Elective Colonoscopy aFter mAnnitol or Standard Split 2-li (Phase 2)
- Budesonide as a Treatment for Low-grade Duodenal Inflammation in Functional Dyspepsia (Phase 4)
- Biomarkers for Intestinal Permeability in Patients With Functional Lower Gastrointestinal Disorders Associated With Constipation. (N/A)
- Comparative Acute Effects of R-MDMA and S-MDMA in Healthy Participants (Phase 1)
- NCT00042471 (Phase 2)
- Effect of Vaxoral® (OM-85) on Frequency of Respiratory Tract Infections and Size of Adenoid Tissue in Preschool Children With Adenoid Hypertrophy (Phase 4)
- Comparison of Four Different Surgical Methods for the Treatment of Sacrococcygeal Pilonidal Sinus: a Randomized Controlled Trial (NA)
- Association Among Maternal Environmental Enteric Dysfunction, Aflatoxin Exposure, and Birth Outcomes: A Prospective Cohort Study in Mukono, Uganda (N/A)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Manitol CI brief — competitive landscape report
- Manitol updates RSS · CI watch RSS
- Reconnect Labs portfolio CI